BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8105156)

  • 21. Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.
    Pastorelli G; Roncarolo MG; Touraine JL; Rousset F; Pene J; de Vries JE
    Clin Exp Immunol; 1989 Dec; 78(3):341-7. PubMed ID: 2575470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking.
    Kindler V; Matthes T; Jeannin P; Zubler RH
    Eur J Immunol; 1995 May; 25(5):1239-43. PubMed ID: 7539752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Kuratsune H; Owada MK; Tokumine Y; Tagawa S; Nojima J; Shibano M; Nishimori Y; Morita T; Machii T; Kitani T
    Leukemia; 1990 Oct; 4(10):700-3. PubMed ID: 2214873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA).
    Miller RA; Gralow J
    J Immunol; 1984 Dec; 133(6):3408-14. PubMed ID: 6436381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective signal transduction through the CD3 or CD2 complex is required for class II MHC expression by human T cells.
    Oshima S; Eckels DD
    J Immunol; 1990 Dec; 145(12):4018-25. PubMed ID: 1979584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human atopen-specific types 1 and 2 T helper cell clones.
    Wierenga EA; Snoek M; Jansen HM; Bos JD; van Lier RA; Kapsenberg ML
    J Immunol; 1991 Nov; 147(9):2942-9. PubMed ID: 1680923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
    Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
    J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells.
    Saiki O; Ralph P
    Eur J Immunol; 1982 Jun; 12(6):506-10. PubMed ID: 6981514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respiratory burst in human B lymphocytes. Triggering of surface Ig receptors induces modulation of chemiluminescence signal.
    Leca G; Benichou G; Bensussan A; Mitenne F; Galanaud P; Vazquez A
    J Immunol; 1991 May; 146(10):3542-9. PubMed ID: 1851193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation.
    Lycke NY
    J Immunol; 1993 Jun; 150(11):4810-21. PubMed ID: 8388421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory effects of IL-4 on human B-cell response to IL-2.
    Galanaud P; Karray S; Llorente L
    Eur Cytokine Netw; 1990; 1(2):57-64. PubMed ID: 2102812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell malignancy in Richter's syndrome presenting as hyper IgM. Induction and characterization of a novel CD3+, CD4-, CD8+ T cell subset from phytohemagglutinin-stimulated patient's CD3+, CD4+, CD8+ leukemic T cells.
    Raziuddin S; Assaf HM; Teklu B
    Eur J Immunol; 1989 Mar; 19(3):469-74. PubMed ID: 2523311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular investigation of the cytokines produced by normal and malignant B lymphocytes.
    Schena M; Gaidano G; Gottardi D; Malavasi F; Larsson LG; Nilsson K; Caligaris-Cappio F
    Leukemia; 1992 Feb; 6(2):120-5. PubMed ID: 1372670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM.
    Defrance T; Vanbervliet B; Pène J; Banchereau J
    J Immunol; 1988 Sep; 141(6):2000-5. PubMed ID: 2971718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
    Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
    Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell surface molecules regulating noncognate B lymphocyte activation. Role of CD2 and LFA-1.
    Sen J; Bossu P; Burakoff SJ; Abbas AK
    J Immunol; 1992 Feb; 148(4):1037-42. PubMed ID: 1346620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 2 induces T cell-dependent IgM production in human B cells.
    Sauerwein RW; Van der Meer WG; Dräger A; Aarden LA
    Eur J Immunol; 1985 Jun; 15(6):611-6. PubMed ID: 3874074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH; Vitetta ES
    J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
    Hirokawa M; Gray JD; Takahashi T; Horwitz DA
    J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.